diabetic cure

Pharmacy

Sun Pharma launches generic Glumetza tablets in US

Franchise India Bureau Jul 25 2018 - 1 min read

Sun Pharmaceutical Industries today said one of its wholly owned subsidiaries has launched generic metformin hydrochloride extended release tablets, used for glycemic control, in the US market. The tablets have been launched in the strengths of 500 mg and 1000 mg, it said in a filing to BSE. The tablets are generic versions of Santarus ...

Share
Diabetes

How India Is Becoming A Home To The Largest Diabetes Drugs Market

Shahram Warsi Jul 13 2018 - 2 min read

A chronic disease, diabetes is characterized by high blood sugar level, caused by the improper functioning of the pancreas. India and China are dominating the BRIC diabetes drug market due to increasing diabetic population and aging people. Funds are being raised for controlling diabetes, boosting the growth of diabetes drugs in India. Technological advancements and ...

Share
Healthcare

Vitamin-D deficiency linked with onset of Diabetes in Indian Women: Study

Franchise India Bureau Jul 03 2018 - 4 min read

Women in India are more likely to have vitamin D deficiency says a multi-stakeholder study conducted by Fortis C- Doc in association with AIIMS, Diabetes Foundation of India and National Diabetes Obesity and Cholesterol Foundation. The cross-sectional study conducted in North India sheds light on the relationship between low vitamin D and high ...

Share
Education

Diabetes Educators: Training To Manage The Disease

Sneha Santra Jun 22 2018 - 2 min read

A major reason behind this rapid increase is lack of awareness about the disease and its causes like poor lifestyle condition. To compound matters, availability of trained medical professionals is not commensurate with the increase in the numbers of the afflicted. Taking serious note of the situation, the Ministry of Skill Development and Entrepreneurship (MSDE) ...

Share
Investment

Blume, Leo Capital Back Diabetes management startup app BeatO

Franchise India Bureau Apr 05 2018 - 2 min read

Diabetes App BeatO Raises $1.3Mn Funding In a round co-led by Blume Ventures and Leo Capital, Delhi-based Health Arx Technologies Pvt. Ltd operated diabetes management app BeatO, has raised $1.3 million (Rs 8.45 crore). The startup plans to use the money received to ramp up its technology backbone as well as ...

Share